Abstract
Prostate cancer in men is the second most occurring cancer in Poland and represents approximately 13.2 % of all cancers. At the same time, it is the third largest cause of death in men, being responsible for approximately 8 % of deaths. The study was conducted among patients of Oncological Hospital in Wieliszew. The study included 83 men diagnosed with prostate cancer at the age of 51–84 years. The patients gave their written consent to participate in the study, to which the overall standardized questionnaires EORTC QLQ-C30 and QLQ-PR25 for patients with prostate cancer was applied. Significant deterioration of the state of health due to cancer was indicated by a total of 10.84 % of patients. At the same time, it was found that although there are differences between quality of life in various age groups of respondents, they are statistically insignificant (Chi2 = 59.96; p = 0.00734; R = 0.09; p > 0.05). Subjective QoL did not depend on the stage of cancer treatment, type of therapy, or significant deterioration in the patient’s state of health in the last stage of disease. Both disease and therapy have impact on quality of life in all its dimensions, in particular as regards the patient’s physical functioning and his frequent fatigue. There is a strong relationship between a patient’s subjective assessment of quality of life and pain that significantly hampers everyday activities. This demonstrates the need for continuous monitoring and relieving pain directly associated with cancer and methods of its treatment.
Similar content being viewed by others
References
Wojciechowska U, Dzikowska J (2013) Nowotwory w Polsce w 2012 roku. Nowotwory J Oncol 63(3):197–216
Zalecenia postępowania diagnostyczno – terapeutycznego w nowotworach złośliwych 2013 rok. Redakcja Krzakowski M., Warzocha K., Gdańsk 2013
Miyake H, Muramaki M, Eto H, Kamidano S, Hara I (2004) Health-related quality of life after chemotherapy for advanced germ cell tumors: a comparison of standard – dose and high – dose chemotherapy. Int J Urol 11:542–546
Kordka R (2007) red., Onkologia. Podręcznik dla studentów i lekarzy. Third edition. Gdańsk
de Walden – Gałuszko K, Majkowicz M (1994) Jakość życia w chorobie nowotworowej, ISBN83-7017-512-0, Wydawnictwo Uniwersytetu Gdańskiego, Gdynia
Nowicki A, Staniewska J, Tesmer I (2007) Ocena jakości życia chorych na raka gruczołu krokowego hospitalizowanych w trakcie radioterapii radykalnej. Cz. I. Współcz Onkol 11:412–418
Monga U, Kerrigan AJ, Thornby J, Monga TN, Zimmermann KP (2005) Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy. J Rehabil Res Dev 42(3):391–399
Janda M, Gerstner N, Obermair A, Fuerst A, Wachter S, Dieckmann K, Potter R (2000) Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 89:1322–1328
Friedman A, Hahn G, Love N (1998) Obserwacja po leczeniu raka gruczołu krokowego. Medycyna po Dyplomie 7:71–78
Zielińska-Więczkowska H, Bełtakowski J (2010) Jakość życia pacjentów z chorobą nowotworową poddanych chemioterapii. Współcz Onkol 14(3):276–280
Bach P, Döring T, Gesenberg A, Möhring C, Goepel M (2011) Quality of life of patients after retropubic prostatectomy—pre- and postoperative scores of the EORTC QLQ-C30 and QLQ-PR25. Health Qual Life Outcomes 9:93
Jayadevappa R, Chhatre S, Whittington R, Bloom BS, Wein AJ, Malkowicz SB (2006) Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. BJU Int 97(5):955–962
Modlińska A, Buss T, Krakowiak P (2009) Ocena jakości życia osób w wieku podeszłym w terminalnym okresie choroby nowotworowej. Przegl Lek 66:479–484
Dunn A, Carter J, Carter H (2003) Anemia at the end of life: prevalence, significance, and causes in patients receiving palliative care. J Pain Symptom Manage 26(6):1132–1139
Sweeney C, Neuenschwander H, Bruera E (2005) Fatigue and asthenia. [w] In: Doyle D, Hanks G, Cherny N, Calman K (red.) Oxford textbook of palliative medicine. Oxford University Press, Oxford, 560–568.
Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage 12(1):3–10
Buss T, Modlińska A, Chełmińska M, Niedoszyto M (2004) Zmęczenie w chorobie nowotworowej. I. Częstość występowania i próba zdefiniowania problemu. Pol Merkur Lekarski 16:70–72
Rodgers JK, Sawhney R, Chaudhary U, Bissada NK (2006) Quality of life in men with localized prostate cancer treated by radical prostatectomy or radiotherapy. Arch Androl 52:129–133
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Patients gave written consent to participate in the study that applied the overall standardized questionnaire EORTC QLQ-C30 (version 3.0) and QLQ-PR25 for patients with prostate cancer, developed by the European Quality of Life Group.
Conflict of Interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Dąbrowska-Bender, M., Słoniewski, R., Religioni, U. et al. Analysis of Quality of Life Subjective Perception by Patients Treated for Prostate Cancer with the EORTC QLQ-C30 Questionnaire and QLQ-PR25 Module. J Canc Educ 32, 509–515 (2017). https://doi.org/10.1007/s13187-015-0954-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-015-0954-5